Pure Global

TGIX 50 MG I.V. POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF SOLUTION FOR INFUSION, 10 PIECES - Turkey License 6ae9c1740938cc82e22495e3799c96c2

Access comprehensive regulatory information for TGIX 50 MG I.V. POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF SOLUTION FOR INFUSION, 10 PIECES in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 6ae9c1740938cc82e22495e3799c96c2 with license number 2022/414and contains active ingredient Tigesiclin . The license is held by DEVA HOLDฤฐNG A.ลž..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
6ae9c1740938cc82e22495e3799c96c2
License Details
Turkey SFDA License: 6ae9c1740938cc82e22495e3799c96c2
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

TGIX 50 MG I.V. POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF SOLUTION FOR INFUSION, 10 PIECES
TR: TGฤฐXEL 50 MG I.V. ฤฐNFรœZYONLUK ร‡ร–ZELTฤฐ HAZIRLAMADA KULLANILACAK KONSANTRE ฤฐร‡ฤฐN TOZ , 10 ADET
Pharmaceutical Product

License Details

6ae9c1740938cc82e22495e3799c96c2

2022/414

8699525790101

J01AA12

License Holder Information

Active Ingredient

Tigesiclin

License Information

Jul 31, 2022